| Schedule of segment reporting information |
The following table presents information by reportable operating segment for the three and six months ended June 30, 2020 and 2019 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Products
Segment |
|
Specialty Pharmaceutical Segment |
|
Consolidated Totals |
| Three months ended June 30, 2020: |
|
|
|
|
|
| Product sales, net |
$ |
5,396 |
|
|
$ |
— |
|
|
$ |
5,396 |
|
|
|
|
|
|
|
| Gross profit |
$ |
2,322 |
|
|
$ |
— |
|
|
$ |
2,322 |
|
| Research and development expense |
152 |
|
|
594 |
|
|
746 |
|
| Selling, general and administrative expense |
6,180 |
|
|
53 |
|
|
6,233 |
|
| Operating loss |
$ |
(4,010) |
|
|
$ |
(647) |
|
|
$ |
(4,657) |
|
|
|
|
|
|
|
| Three months ended June 30, 2019: |
|
|
|
|
|
| Product sales, net |
$ |
16,854 |
|
|
$ |
— |
|
|
$ |
16,854 |
|
|
|
|
|
|
|
| Gross profit |
$ |
11,951 |
|
|
$ |
— |
|
|
$ |
11,951 |
|
| Research and development expense |
679 |
|
|
1,009 |
|
|
1,688 |
|
| Selling, general and administrative expense |
8,999 |
|
|
10 |
|
|
9,009 |
|
| Operating income (loss) |
$ |
2,273 |
|
|
$ |
(1,019) |
|
|
$ |
1,254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Products
Segment |
|
Specialty Pharmaceutical Segment |
|
Consolidated Totals |
| Six months ended June 30, 2020: |
|
|
|
|
|
| Product sales, net |
$ |
13,666 |
|
|
$ |
— |
|
|
$ |
13,666 |
|
|
|
|
|
|
|
| Gross profit |
$ |
6,330 |
|
|
$ |
— |
|
|
$ |
6,330 |
|
| Research and development expense |
457 |
|
|
1,798 |
|
|
2,255 |
|
| Selling, general and administrative expense |
13,990 |
|
|
62 |
|
|
14,052 |
|
| Operating loss |
$ |
(8,117) |
|
|
$ |
(1,860) |
|
|
$ |
(9,977) |
|
|
|
|
|
|
|
| Six months ended June 30, 2019: |
|
|
|
|
|
| Product sales, net |
$ |
31,765 |
|
|
$ |
— |
|
|
$ |
31,765 |
|
|
|
|
|
|
|
| Gross profit |
$ |
22,510 |
|
|
$ |
— |
|
|
$ |
22,510 |
|
| Research and development expense |
1,378 |
|
|
1,652 |
|
|
3,030 |
|
| Selling, general and administrative expense |
27,584 |
|
|
20 |
|
|
27,604 |
|
| Operating loss |
$ |
(6,452) |
|
|
$ |
(1,672) |
|
|
$ |
(8,124) |
|
|